



CEGEDIM: Cegedim Strategic Data (CSD): the First Company to Provide Longitudinal Patient Data in the Top 5 Europe
PARIS--(Marketwire - April 6, 2009) - Cegedim Strategic Data, leading provider of healthcare research, reinforces its Patient and Medical Research offers by securing its position as the first company to provide Longitudinal Patient Data in the top 5 European countries: France, Germany, Italy, Spain and the UK.
CSD's Patient offer provides a wide range of analyses based on real-life observational patient data. This offer can help define a pharmaceutical company's strategic options when it comes to managing portfolio lifecycle challenges and future opportunities. Examples of studies include: market share in Rx and patients, prescriptions and co-prescriptions, patient profiles, dynamic segments.
CSD's Medical Research department has a dedicated team in each of the top 5 European countries and can provide pharmaco-epidemiological studies, disease prevalence, risk management, health economics and outcome studies.
Bruno Sarfati, CSD CEO declared: "With this strengthening of the Patient and Medical Research offers, CSD creates more value for its clients and will continue to extend these offers in the future."
CSD has also longitudinal patient databases in Australia, Belgium, Czech Republic, and Korea.
About Cegedim Strategic Data:
CSD is a Market Research company dedicated to the healthcare industry and operating in more than 58 countries. With over 35 years experience in the Pharmaceutical industry, CSD offers a comprehensive range of market research services and solutions to its customers, which include more than 50 global and 500 local Pharmaceutical companies. CSD integrates primary and secondary analyses with its medical expertise to meet its customer's research needs.
To learn more, please visit our website: [ www.cegedimstrategicdata.com ]
About Cegedim:
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies.
The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs more than 8,400 people in 80 countries and generated revenue of EUR 849 million in 2008. To learn more, please visit our website: [ www.cegedim.com ]
Listed on NYSE Euronext Paris, compartment B - ISIN FR0000053506 - Reuters CGDM.PA - Bloomberg CGM